TherapeuticsMD (TXMD) Gross Profit Growth (5y) (2016 - 2023)
TherapeuticsMD (TXMD) Gross Profit Growth (5y) (2016 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | TherapeuticsMD | 23.78 Mn | 14.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -34.42% |
| Sep 30, 2023 | -15.09% |
| Jun 30, 2023 | -33.30% |
| Mar 31, 2023 | -33.25% |
| Dec 31, 2022 | 81.00% |
| Mar 31, 2022 | 34.19% |
| Dec 31, 2021 | 29.84% |
| Sep 30, 2021 | 36.17% |
| Jun 30, 2021 | 41.96% |
| Mar 31, 2021 | 31.76% |
| Dec 31, 2020 | 31.06% |
| Sep 30, 2020 | 32.08% |
| Jun 30, 2020 | 10.56% |
| Mar 31, 2020 | 22.68% |
| Dec 31, 2019 | 30.99% |
| Sep 30, 2019 | 48.18% |
| Jun 30, 2019 | 11.06% |
| Mar 31, 2019 | 9.75% |
| Dec 31, 2018 | 344.10% |
| Sep 30, 2018 | 341.94% |